Literature DB >> 16929310

On the art of identifying effective and specific siRNAs.

Yi Pei1, Thomas Tuschl.   

Abstract

Small interfering RNAs (siRNAs) have been widely exploited for sequence-specific gene knockdown, predominantly to investigate gene function in cultured vertebrate cells, and also hold promise as therapeutic agents. Because not all siRNAs that are cognate to a given target mRNA are equally effective, computational tools have been developed based on experimental data to increase the likelihood of selecting effective siRNAs. Furthermore, because target-complementary siRNAs can also target other mRNAs containing sequence segments that are partially complementary to the siRNA, most computational tools include ways to reduce potential off-target effects in the siRNA selection process. Though these methods facilitate selection of functional siRNAs, they do not yet alleviate the need for experimental validation. This perspective provides a practical guide based on current wisdom for selecting siRNAs.

Mesh:

Substances:

Year:  2006        PMID: 16929310     DOI: 10.1038/nmeth911

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  96 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

2.  Development of a siRNA and shRNA screening system based on a kinase fusion protein.

Authors:  Sofie Pieraets; Luk Cox; Olga Gielen; Jan Cools
Journal:  RNA       Date:  2012-04-26       Impact factor: 4.942

3.  Strand-specific 5'-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity.

Authors:  Po Yu Chen; Lasse Weinmann; Dimos Gaidatzis; Yi Pei; Mihaela Zavolan; Thomas Tuschl; Gunter Meister
Journal:  RNA       Date:  2007-12-19       Impact factor: 4.942

4.  Effect of target secondary structure on RNAi efficiency.

Authors:  Yu Shao; Chi Yu Chan; Anil Maliyekkel; Charles E Lawrence; Igor B Roninson; Ye Ding
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

5.  A method for detecting and preventing negative RNA interference in preparation of lentiviral vectors for siRNA delivery.

Authors:  Demin Zhou; Jing Zhang; Cuiying Wang; Joshua R Bliesath; Qiuchen He; Dehua Yu; Zhang Li-He; Flossie Wong-Staal
Journal:  RNA       Date:  2009-02-25       Impact factor: 4.942

6.  A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery.

Authors:  David N Nguyen; Phillip Kim; Luis Martínez-Sobrido; Brett Beitzel; Adolfo García-Sastre; Robert Langer; Daniel G Anderson
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

7.  A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.

Authors:  Carlos Gorbea; Kimberly A Makar; Matthias Pauschinger; Gregory Pratt; Jeathrina L F Bersola; Jacquelin Varela; Ryan M David; Lori Banks; Chien-Hua Huang; Hua Li; Heinz-Peter Schultheiss; Jeffrey A Towbin; Jesús G Vallejo; Neil E Bowles
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

8.  Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting.

Authors:  J Kaplan; F S Kaplan; E M Shore
Journal:  Gene Ther       Date:  2011-10-20       Impact factor: 5.250

9.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

10.  Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).

Authors:  Olga B Garbuzenko; Vera Ivanova; Vladislav Kholodovych; David C Reimer; Kenneth R Reuhl; Edvard Yurkow; Derek Adler; Tamara Minko
Journal:  Nanomedicine       Date:  2017-04-19       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.